Walleye Trading LLC Clovis Oncology, Inc. Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 08, 2022	SELL	$0.63 - $2.96 $8,946 - $42,032	-14,200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $5,434 - $11,932	3,800 Added 36.54%	14,200 $29,000
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $52,920 - $93,296	-19,600 Reduced 65.33%	10,400 $28,000
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $95,003 - $135,720	23,400 Added 354.55%	30,000 $134,000
Q2 2021 Aug 16, 2021	SELL	$5.02 - $7.05 $30,119 - $42,300	-6,000 Reduced 47.62%	6,600 $38,000
Q1 2021 May 17, 2021	SELL	$4.81 - $10.34 $5,771 - $12,408	-1,200 Reduced 8.7%	12,600 $88,000
Q4 2020 Feb 16, 2021	SELL	$4.13 - $6.41 $46,256 - $71,792	-11,200 Reduced 44.8%	13,800 $66,000
Q3 2020 Nov 16, 2020	BUY	$4.82 - $7.72 $21,208 - $33,968	4,400 Added 21.36%	25,000 $146,000
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $88,764 - $151,164	-15,600 Reduced 43.09%	20,600 $139,000
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $252,590 - $737,000	-67,000 Reduced 64.92%	36,200 $230,000
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $79,200 - $433,752	-26,400 Reduced 20.37%	103,200 $1.08 Million
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $376,887 - $1.47 Million	95,900 Added 284.57%	129,600 $509,000
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $316,407 - $634,049	24,700 Added 274.44%	33,700 $501,000
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $158,940 - $272,520	9,000 New	9,000 $223,000
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $9,304 - $26,136	-800 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $740,124 - $1.25 Million	-25,200 Reduced 96.92%	800 $23,000
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $1.09 Million - $1.62 Million	26,000 New	26,000 $1.18 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account